Experience of transitional cell carcinoma after renal allograft

Keun Wook Lee, Koon Ho Rha, Seung Choul Yang

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: The increased incidence of urologic malignancy, especially transitional cell carcinoma in patient after renal allograft is well known. The aim of this study was to analyze the development of transitional cell carcinoma and its management. Materials and Methods: Of 2,092 patients who underwent renal allograft at Severance hospital between April 1986 and August 2003, 10 (0.48%) had urologic malignancies. The clinical variables collected were patient age, age at renal allograft, cancer diagnosis time since renal allograft, cancer site, TNM stage, pathology and grade, treatment, recurrence and follow up tool. Results: There were 6 men (median age at renal allograft 49.6, median age at cancer diagnosis 57.6) and 4 women (median age at renal allograft 54.5, median age at cancer diagnosis 62.8). There were two adenocarcinoma of prostate patients (0.10%), six transitional cell carcinoma patients (0.29%) and two squamous cell carcinoma of penis patients (0.10%). Sites of transitional cell carcinoma were bladder in five patients, renal pelvis in three patients, ureter in two patients, respectively. As a treatment, nephroureterectomy with bladder cuff resection for transitional cell carcinoma of renal pelvis or ureter, transurethral resection of bladder tumor with mitomycin C intravesical instillation for transitional cell carcinoma of bladder were done. No recurrence or metastasis was observed except transitional cell carcinoma of bladder. In four of five transitional cell carcinoma of bladder patients, multiple recurrences more than three times were observed. Conclusions: In patients after renal allograft, the transitional cell carcinoma always should be highly suspected. Aggressive follow up and management are indicated.

Original languageEnglish
Pages (from-to)241-245
Number of pages5
JournalKorean Journal of Urology
Volume46
Issue number3
Publication statusPublished - 2005 Mar 1

Fingerprint

Transitional Cell Carcinoma
Allografts
Kidney
Urinary Bladder
Kidney Pelvis
Kidney Neoplasms
Ureter
Recurrence
Neoplasms
Intravesical Administration
Penis
Mitomycin
Urinary Bladder Neoplasms
Prostate
Squamous Cell Carcinoma
Adenocarcinoma
Pathology
Neoplasm Metastasis

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Lee, Keun Wook ; Rha, Koon Ho ; Yang, Seung Choul. / Experience of transitional cell carcinoma after renal allograft. In: Korean Journal of Urology. 2005 ; Vol. 46, No. 3. pp. 241-245.
@article{7ab5d295fd8740afad7a93dc911cb812,
title = "Experience of transitional cell carcinoma after renal allograft",
abstract = "Purpose: The increased incidence of urologic malignancy, especially transitional cell carcinoma in patient after renal allograft is well known. The aim of this study was to analyze the development of transitional cell carcinoma and its management. Materials and Methods: Of 2,092 patients who underwent renal allograft at Severance hospital between April 1986 and August 2003, 10 (0.48{\%}) had urologic malignancies. The clinical variables collected were patient age, age at renal allograft, cancer diagnosis time since renal allograft, cancer site, TNM stage, pathology and grade, treatment, recurrence and follow up tool. Results: There were 6 men (median age at renal allograft 49.6, median age at cancer diagnosis 57.6) and 4 women (median age at renal allograft 54.5, median age at cancer diagnosis 62.8). There were two adenocarcinoma of prostate patients (0.10{\%}), six transitional cell carcinoma patients (0.29{\%}) and two squamous cell carcinoma of penis patients (0.10{\%}). Sites of transitional cell carcinoma were bladder in five patients, renal pelvis in three patients, ureter in two patients, respectively. As a treatment, nephroureterectomy with bladder cuff resection for transitional cell carcinoma of renal pelvis or ureter, transurethral resection of bladder tumor with mitomycin C intravesical instillation for transitional cell carcinoma of bladder were done. No recurrence or metastasis was observed except transitional cell carcinoma of bladder. In four of five transitional cell carcinoma of bladder patients, multiple recurrences more than three times were observed. Conclusions: In patients after renal allograft, the transitional cell carcinoma always should be highly suspected. Aggressive follow up and management are indicated.",
author = "Lee, {Keun Wook} and Rha, {Koon Ho} and Yang, {Seung Choul}",
year = "2005",
month = "3",
day = "1",
language = "English",
volume = "46",
pages = "241--245",
journal = "Korean Journal of Urology",
issn = "2005-6737",
publisher = "Korean Urological Association",
number = "3",

}

Experience of transitional cell carcinoma after renal allograft. / Lee, Keun Wook; Rha, Koon Ho; Yang, Seung Choul.

In: Korean Journal of Urology, Vol. 46, No. 3, 01.03.2005, p. 241-245.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Experience of transitional cell carcinoma after renal allograft

AU - Lee, Keun Wook

AU - Rha, Koon Ho

AU - Yang, Seung Choul

PY - 2005/3/1

Y1 - 2005/3/1

N2 - Purpose: The increased incidence of urologic malignancy, especially transitional cell carcinoma in patient after renal allograft is well known. The aim of this study was to analyze the development of transitional cell carcinoma and its management. Materials and Methods: Of 2,092 patients who underwent renal allograft at Severance hospital between April 1986 and August 2003, 10 (0.48%) had urologic malignancies. The clinical variables collected were patient age, age at renal allograft, cancer diagnosis time since renal allograft, cancer site, TNM stage, pathology and grade, treatment, recurrence and follow up tool. Results: There were 6 men (median age at renal allograft 49.6, median age at cancer diagnosis 57.6) and 4 women (median age at renal allograft 54.5, median age at cancer diagnosis 62.8). There were two adenocarcinoma of prostate patients (0.10%), six transitional cell carcinoma patients (0.29%) and two squamous cell carcinoma of penis patients (0.10%). Sites of transitional cell carcinoma were bladder in five patients, renal pelvis in three patients, ureter in two patients, respectively. As a treatment, nephroureterectomy with bladder cuff resection for transitional cell carcinoma of renal pelvis or ureter, transurethral resection of bladder tumor with mitomycin C intravesical instillation for transitional cell carcinoma of bladder were done. No recurrence or metastasis was observed except transitional cell carcinoma of bladder. In four of five transitional cell carcinoma of bladder patients, multiple recurrences more than three times were observed. Conclusions: In patients after renal allograft, the transitional cell carcinoma always should be highly suspected. Aggressive follow up and management are indicated.

AB - Purpose: The increased incidence of urologic malignancy, especially transitional cell carcinoma in patient after renal allograft is well known. The aim of this study was to analyze the development of transitional cell carcinoma and its management. Materials and Methods: Of 2,092 patients who underwent renal allograft at Severance hospital between April 1986 and August 2003, 10 (0.48%) had urologic malignancies. The clinical variables collected were patient age, age at renal allograft, cancer diagnosis time since renal allograft, cancer site, TNM stage, pathology and grade, treatment, recurrence and follow up tool. Results: There were 6 men (median age at renal allograft 49.6, median age at cancer diagnosis 57.6) and 4 women (median age at renal allograft 54.5, median age at cancer diagnosis 62.8). There were two adenocarcinoma of prostate patients (0.10%), six transitional cell carcinoma patients (0.29%) and two squamous cell carcinoma of penis patients (0.10%). Sites of transitional cell carcinoma were bladder in five patients, renal pelvis in three patients, ureter in two patients, respectively. As a treatment, nephroureterectomy with bladder cuff resection for transitional cell carcinoma of renal pelvis or ureter, transurethral resection of bladder tumor with mitomycin C intravesical instillation for transitional cell carcinoma of bladder were done. No recurrence or metastasis was observed except transitional cell carcinoma of bladder. In four of five transitional cell carcinoma of bladder patients, multiple recurrences more than three times were observed. Conclusions: In patients after renal allograft, the transitional cell carcinoma always should be highly suspected. Aggressive follow up and management are indicated.

UR - http://www.scopus.com/inward/record.url?scp=19144369898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19144369898&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:19144369898

VL - 46

SP - 241

EP - 245

JO - Korean Journal of Urology

JF - Korean Journal of Urology

SN - 2005-6737

IS - 3

ER -